BPC-157's regulatory status continues evolving
As a doctor, theres a lot of burden on your shoulders when you are prescribing something with insufficient evidence, but the patients insist on giving it a try. With no formal approvals surrounding their use from regulatory bodies like the Drugs Controller General of India (DCGI), they are considered off-label treatments
Does the serum disclose its INCI
FOXO4-DRI: A Deep Dive Into the Senolytic Peptide Rebooting Cellular Ageing Introduction In the field of longevity medicine and anti-ageing research, the focus has shifted from merely managing the consequences of ageing toward confronting the underlying cellular processes themselves
Content Peptides are widely used in modern research, biotechnology, and laboratory-based protocols due to their diverse functions, predictable metabolism, inflammation modulation, and highly targeted activity